1-4 of 4
Alejandro Martin Garcia-Sancho
Close
Sort by
Journal Articles

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

Clinical Trials & Observations
Loretta J. Nastoupil, Georg Hess, Miguel A. Pavlovsky, Iwona Danielewicz, Jane Freeman, Alejandro Martin García-Sancho, Valeria Glazunova, Andrew Grigg, Jing-Zhou Hou, Ann Janssens, Seok Jin Kim, Zvenyslava Masliak, Pam McKay, Francesco Merli, Wataru Munakata, Hirokazu Nagai, Muhit Özcan, Meir Preis, Tingyu Wang, Melissa Rowe, Monelle Tamegnon, Rui Qin, Todd Henninger, Madeliene Curtis, Donne Bennett Caces, Catherine Thieblemont, Gilles Salles
Journal: Blood Advances
Blood Adv (2023) 7 (22): 7141–7150.
https://doi.org/10.1182/bloodadvances.2023010298
Published: 2023
Includes: Supplemental data
Journal Articles

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A. van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucia Lopez-Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martin Garcia-Sancho, Pier Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3606–3610.
https://doi.org/10.1182/bloodadvances.2021006922
Published: 2022
Includes: Supplemental data
Journal Articles

Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP

Clinical Trials & Observations
Sophie Bernard, Herve Ghesquieres, Rene-Olivier Casasnovas, Samuel Griolet, Maria Gomes da Silva, Pierre Feugier, Franck Morschhauser, Judith Trotman, Loic Renaud, Richard Greil, Alejandro Martín García-Sancho, Sebastian Grosicki, Koen van Eygen, Christiane Copie-Bergman, Corinne Haioun, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2965–2968.
https://doi.org/10.1182/bloodadvances.2021004766
Published: 2021
Includes: Supplemental data
Journal Articles

A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease

Clinical Trials & Observations
Turner S. Baker, Kristyne J. Gambino, Lawrence Schriefer, Jung-Yeon Lim, Karyn Meltz Steinberg, David C. Fajgenbaum, Alejandro Martín García-Sancho, Minji Byun
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2959–2963.
https://doi.org/10.1182/bloodadvances.2018023911
Published: 2018
Includes: Supplemental data